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The binding of fibronectin and fibronectin fragments to the cnterotoxigenic strain E. co/i B34289c was studied. E. coli cells bound to two distinct 
sites of fbronectin, one being the N-terminal domain, which also contains the binding sites for staphylococci and streptococci. and the other located 
within the sentrat heparin binding region. In addition, the N-terminal and the heparin binding domain mediated the attachment of bacteria in a 
solid phase binding assay. E. co/i cells expressed two classes of rcccptors, the first, a 17 kDa protein, recognized by the N-terminai fragment and 
the second, having a mol. mass of 55 kDa, which interacts with the internal heparin binding domain. Bacterial receptors, which bind the N-terminal 
end of fibronectin, may be structurally related. 
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1.. INTRODlJCTION 
Fibronectin is a disulfide linked dimeric glycoprotcin 
(M, 550 000) which is present in soluble form in body 
fluids and in a fibrillar form in the extracellular matrix. 
Fibronectin has a wide range of functional activities. Its 
major function is probably related to the ability to me- 
diate adhesion of eucariotic cells to the extracellular 
matrix [l]. Fibronectin can also bind specifically to a 
number of important macromolecules such as collagen, 
fibrin and glycosaminoglycans [Z]. Moreover, fibronec- 
tin interacts with some pathogenic bacteria and it is 
believed that this binding may represent a mechanism 
of tissue adherence [3]. The main binding site for sta- 
phylococci and streptococci and some Gram-negative 
microorganisms has been located to the N-terminal do- 
main of fibronectin, but, there are indications for a 
second binding site in the C-terminal region of the mo- 
le~ule [4]. However, this binding site has not yet been 
located to a specific domain in the fibronectin molecule. 
Enterotoxigenic E. coli are the major causative ente- 
ropathogen in young piglets, lambs and calves and may 
induce severe diarrhea in humans. The pathogenesis of 
infection may involve the ability of bacteria to adhere 
to the adhesive proteins of subephitelial amina propria 
and the production of non-cytotoxic enterotoxins. 
In the present communication, we report on the bind- 
ing of fibronectin and its preoteolytic fragments to the 
enterotoxigenic E. coli B34289c and show that there are 
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two separate binding sites in fibronectin, which recog- 
nize two distinct structures on the bacterial ceII surface. 
Furthermore, the relationship between fibronectin 
binding components from E. coii and those from sta- 
phylococci and streptococci is analyzed. 
2. MATEWI[AES AND METHODS 
Fibronectin was purified from human plasma [§I. 
Thermolysin-generated fibronectin fragments (i.e. the N-terminal 
domain, the collagen binding fragment and the fragment containing 
eucaryotic cell binding region) were isolated as reported by Borsi et 
al. 161. The internal heparin binding domain from bovine plasma 
fibroncctin was purified following the protocol described by Skorsten- 
gaard et al. [7]. The COOH-terminal fragment containing a fibrin- 
binding site was isolated following the procedure by Garcia-Pardo et 
al. 181. 
Carrier free ‘*‘I (specific activity, 15 mCi&g) was purchased from 
Amersham, UK. Proteins were labeled with “‘1 by the Chloramine T 
method [9]. The specific activity of the radioactively labeled ligands 
was estimated to be 4.2 x IO’ cpm@g for fibronectin, 3 x IO’ cpm/flg 
for the N-terminal fragment of fibronectin and 2.6 x IO” cpmlpg for 
the internal heparin binding site. 
The strain used for this study, E. coli B34289c, belongs to serotype 
06zK2:M and was previously shown to bind fibronectin [IO] and 
collagen [I I]. 
Bacteria were grown in CFA agar medium [12] at 30°C for 24 h. 
Cells were scraped from the agar gel surface, suspended in phosphate- 
buffered saline (PBS) (0.13 M sodium chloride, 0.02% sodium azide, 
10 mM phosphate, pH 7.4), washed and used for binding experiments. 
The assay of fibronectin binding to bacteria was carried out as 
reported previously [ 131. 
Radiolabeling of bacteria was performed by the iodogen method 
following the procedure recommended by the manufacturer (Pierce). 
The specific activity of the bacterial preparation was about 5 x IO” 
cpm/6 x 10’ cells. 
Coating of microtiter plates (Immulon 2; Dynatech) with fibronec- 
tin and fibronectin fragments and the attachment assays of bacteria 
were carried out as previously reported [lo]. 
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The staphylococsal fusion protein, called ZZ-FR, containing two 
IgG-binding domains of protein A and a segment of fibronectin recep- 
tor containing three fibronectin binding repeats [5] was a gift from G. 
Raucci (Menarini Ricerche Sud, Italy). The method used for purifying 
fibronectin receptor from S. clysgaluctiae S2 will bc described in detail 
elsewhere. 
ABe DE F 
Electrophoresis in 10% or 5-l 5% polyacrylamide gradient gels was 
performed according to Blobel and Dobberstein [l6]. Rlotting was 
performed essentially using the procedure of Towbin et al. [ 171. Radio- 
active components were visualized by autoradiography of dried gels 
.-. C. or mtrocellu!ose sheets usmg X-Umat AK wtii \I.cw~~.~.~ ..l..._..,. ~~““.rn.... uOrJ51t) 
3. RESULTS AND DISCUSSIION 
To identify the fibronectin sites involved in binding 
to E. coli fibronectin fragments obtained after trypsin 
digestion were labeled by ‘Wodination, incubated with 
bacteria and cell bound peptides were then analyzed by 
gel electrophoresis, followed by autoradiography (Fig. 
I). 
Fig. 2. Electrophoretic analysis of fibronectin fragments. Fibronectin 
fragments obtained as reported in section 2 were analyzed on SDS- 
polyacrylamide gel (10%) under unreduced conditions. Lane A, intact 
fibronectin; lane B, N-terminal 28 kDa fragment; lane C, the gelatin- 
binding domain; iane D, tke cell binding fragment: lane E, internal 
heparin binding peptide; lane F, COOH-terminal binding fihrin do- 
main. Positions of molecular-mass markzra are indicated on the left. 
Bacteria bound to two distinct sites of the molecule, 
one being an M, = 28 kDa fragment and the other a 
large fragment with a molecular mass of 180-200 kDa. 
For comparison, fragments binding to S. uwvus strain 
Newman or Streptococcus dysgalactiae S2 were analy- 
zed and both these strains bound only a M, = 28 000 
fragment, presumably the amino-terminal domain [I SJ. 
To localize bacteriai binding domains more precisely 
different fibronectin fragments were isolated ‘(Fig. 2> 
and tested for their ability to inhibit [‘2SI]fibronectin 
binding to bacteria. The results of this experiment (Fig. 
3) showed that the N-terminal region (28 kDa) and a 
fragment corresponding to the internal heparin binding 
domain (30 kDa) of fibronectin reduced the binding of 
[‘251]fibronectin to E. celi sells by 40% and TO%, respec- 
tively. Co-incubation of bacteria with equimolar con- 
centrations of both peptides resulted in more than 90% 
inhibition of fibronectin binding to bacteria. in con- 
trast, the collagen binding domain present in the 40 kDa 
fragment of fibronectin did not interfere with the bind- 
ing. Furthermore, the fragment encompassing the RGD 
containing cell binding site (110 kDa) and C- terminal 
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Fig. I. Electrophoretic analysis of “‘I-labeled fibroncctin fragments 
binding to bacteria. The ‘2SI-labeled fibronectin fragments were in- 
cubated with cells of Staphylococcus aureas Newman, Streptococcus 
dysgalactiae S2 and Escherichia coli B34289c and the cell-bound ma- 
terial was analyzed by electrophoresis under reducing conditions with 
a S-15% gradient gel followed by autoradiography. Lanes C, E and 
G, peptides adsorbed on the surface of S. aureus Newman, S. dys- 
gahctiae S2 and E, co/i B34289c, respectively; lanes I$ D and F, 
peptides remaining in the supernatant of the incubation mixtures; lane 
A, unfractionated fibroncctin fragments. The arrows and numbers 
indicate the migration distances of standard proteins and their molec- 
ular weights. 
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Fig. 3. Effect of fibronectin fragments on the binding of ‘251-labeled 
fibronectin to E. coli cells. Bacteria (5 X IO8 cells) were incubated for 
I h with I2 ng (5 x IO4 cpm) of ‘zSI-labeled fibronectin in the presence 
of increasing concentrations of unlabeled fibronectin (o), N-terminal 
fragment (o), internal heparin binding domain (n) or equimolar 
amounts of both peptides (e) (panel A). In panel B the effect of 
gelatin binding domain (*), cell bizding fragment (A), and C-terminal 
fibrin binding domain of fibronectin ( ) is reported. Binding is ex- 
pressed as percentage of control, i,e. incubations in the absence of 
unlabeled proteins. 
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Fig. 4. Attachment of 12sI-iabeied ceils of $. coli B 34289~ to fibroneciin 
and fibronectin fragments. Radiolabeled bacteria (6 x i06) were incu- 
ba:ed at 37°C in microtiter wells precoated with 5 @g of fibronectin 
or fibronectin fragments. Foilowing 3 h incubation at 37°C the wells 
were washed and bacterial adhesion was quantitated as described in 
section 2. Bars represent standard deviations from the means of three 
determinations. 
fibrin binding domain (31 kDa) lacked inhibitory activ- 
iiy. GidSiiZit %Gth t!X p,eU,...,w _. r CD~FP nfi~/O birocl_ing sites, 
the E. coii C&S bound both the ‘251-labeled N-terminal 
fragment or ‘25i-labeled heparin binding domain of fi- 
bronectin in a time-dependent manner (unpublished 
results). 
The role of the fibronectin fragments in substrate 
adherence of E. coli cells was determined by developing 
a solid-phase binding assay. Microtiter. wells coated 
with intact fibronectin and with its different domains 
were used as substrate for the adherence of surface- 
labeled bacteria. The results (Fig. 4) indisate that baete- 
ria attached to wells coated with fibronectin, with the 
N-terminal fragment and the C-terminal heparin bind- 
ing peptide. 
On the contrary, E. co/i cells did not attach to the 
other fibronectin fragments. Taken together, these data 
indicate that two distinct domains of fibronectin can 
A 
Fig. 5. Eiectrobiotting of E. co/i extracts separated by poiyacryiamide 
gel eiectrophoresis. IBacteria (5 x iO’O/mi) were extracted at 65°C for 
30 min in the presence of 0.5% SDS and fractionated by eiectrophore- 
sis on 515% poiyacrylamide gradient gel. The proteins in the gel were 
eiectroblotted onto nitrocellulose paper and probed with the ‘251~~ 
labeled 28 kDa fragment (lane A) or the ‘2SI-labeled 30 kDa peptide 
(lane B), The molecular masses of proteins are indicated by arrows and 
numbers on the left side. 
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Fig. 6. Inhibition of fibronectin binding to E. CON B34289c by staphy- 
iococcai and streptocoscal fibronectin receptors. Fusion protein ZZ- 
FR (pancis A, B and C) and Streptococcus dysgalactiue S2 purified 
receptor (panels D, E and F) were tested as inhibitors of binding of 
l”‘I]fibronectin (panels a and D), ‘2SI-iabeied N-terminal fragments 
(panels B and E) and ‘ZSI-iabeied heparin binding peptide (panels C 
and F) to E. co/i strain B342g9c. Data are expressed as percentage of 
inhibition where binding to bacteria incubated in theabsence ofpoten- 
tiai inhibitors was set as 0%. 
mediate the adherence of the enterotoxigenic strain of 
E. coli B34289c. 
To identify components that may act as bacterial cell 
surface receptors for fibronectin, extracts from 8. coli 
cells were prepared, separated on SDS-PAGE and 
transferred to nitrocellulose paper. Nitrocellwlose blots 
were incubated with ‘251-labeled 28 kDa or radiolabeled 
30 kDa domains of fibronectin, rinsed and autoradio- 
graphed (Fig. 5). A single 17 kDa reactive band was 
positive with the 1251-labeled 28 kDa peptide, whereas 
the radio- iodinated heparin binding peptide detected a 
protein with a molecular mass of 55 kDa. The 17 kDa 
peptide, recognized by the I’d-terminal fragment may 
represent curlin, a recenP A .J Uescri’oed structural subunit 
of organelles, named curli, having fibronectin binding 
activity [19]. The information we have concerning the 
55 kDa protein, which binds to the internal 30 kDa 
peptide of fibronectin, is much more limited. It is pos- 
sible that the expression and assembly of these two 
classes of receptors are under the same co-ordinated 
control. En fact, the binding of both the N-terminal 
domain and the heparin binding fragment to E. coli was 
maximal for bacteria grown at 30°C and was abolished 
when bacteria were cultured at 3941°C (unpublished 
results). 
The relationship between fibronectin binding compo- 
nents from E. coli and those from staphylococci and 
streptococci was analyzed by testing the chimeric pro- 
tein ZZ-FR, which contains the active site of fibronectin 
binding protein from 5’. aureus and a fibronectin re- 
ceptor isolated from Streptococcus dysgalactiae S2 as 
potential inhibitors of the binding of fibronectin and 
fibronectin fragments to E. coli cells. Our data demon- 
strate that staphylococcal and streptococcal receptors 
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were efficient inhibitors of the binding of the radio- [4] Kuusela, P., Vartio, T., Vuento, M. and Myhre, E.B. (1984) 
iodinated N-terminal fibronectin fragment to bacteria. 
Moreover, they reduced the binding of intact fibro- 
nectin to E. coli B 34X%, but they did not interfere with 
that of internal heparin binding domain (Fig. 6). In view 
of these observations, it is reasonable to assume that 
bacterial receptors interacting with the N-terminal frag- 
trrent recognize and bind to the same site in the domain 
and that they are somehow related, although competi- 
tion between structaarally different components cannot 
be ruled out. In addition, these results suggest hat the 
N-terminal fragment binding receptors differ from the 
55 kBa receptor protein. 
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